CTRI/2021/06/034254已完成未知
Randomized controlled clinical trial to assess the efficacy and safety of APMV2020 in mild symptomatic subjects of COVID 19 - Nil
Meyer Organics Pvt Ltd0 个研究点目标入组 320 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age -18- 60 years (Both sex)
- •2.Confirmed COVID 19 patient with positive RT-PCR
- •3.Mild symptomatic patients having no signs of severe disease (NEWS score ââ?°Â¤6)
- •4.Home/ institutional quarantined subjects with no necessity of dedicated hospital admission at the time of screening
- •5.Subject willing to provide consent and follow up for study duration
排除标准
- •1.Patients with autoimmune disease or self-reports HIV or syphilis infection
- •2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator
- •3.Proves to be unfit for the study as per the investigatorââ?¬•s discretion
- •4.Pregnant or lactating women
- •5.Requiring hospital admission at screening
- •6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation
研究者
相似试验
尚未招募
2 期
To study the effect of ayurvedic formulation in sciaticaCTRI/2024/07/071306Dr Aishwarya ghatage
尚未招募
3 期
Clinical trial of Tagar Tablet in Hypertension.CTRI/2024/03/064721Dr Vidya Rajendra Jatti
已完成
不适用
Randomised controlled trial to assess the clinical- and cost-effectiveness of physiotherapy and occupational therapy in Parkinson's diseaseNervous System DiseasesParkinson's diseaseISRCTN17452402niversity of Birmingham (UK)750
招募中
不适用
Randomized controlled clinical study to assess the clinical efficacy of the 3M* Coban* 2 Layer Compression System compared to a short-stretch compression bandage in the treatment fo venous leg ulcerstreatment of venous leg ulcer1004704310057165NL-OMON310993M Deutschland GmbH, Medical Markets Laboratory60
尚未招募
不适用
Randomized controlled clinical study to evaluate a web application (App) to manage and optimize medicatioHeart failureT78K71K74I12.0I13N18N14I10E78I25E11I50E14Y57.9Adverse effects, not elsewhere classifiedToxic liver diseaseFibrosis and cirrhosis of liverHypertensive renal disease with renal failureHypertensive heart and renal diseaseDrug- and heavy-metal-induced tubulo-interstitial and tubular conditionsEssential (primary) hypertensionDisorders of lipoprotein metabolism and other lipidaemiasChronic ischaemic heart diseaseType 2 diabetes mellitusUnspecified diabetes mellitusDrug or medicament, unspecifiedChronic kidney diseaseDRKS00027175Charité Campus Virchow-Klinikum128